Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate
Ended Project Grant Awarded Last action
- Award ID
- R42AG062095
- Recipient
-
Neurokine Therapeutics LLC UEI E3KLEENGVBR5
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,155,525
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- New York, NY 10025, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $631,965 | |
| Amendment | $2,018,653 | |
| Amendment | $0 | |
| Original award | $504,907 |
Quick answers
Who received award R42AG062095?
R42AG062095 was awarded to Neurokine Therapeutics LLC by National Institute on Aging (National Institutes of Health) on September 30, 2018.
How much is award R42AG062095 worth?
$3,155,525 has been obligated on R42AG062095.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award